Clinical Trial Update: Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase II cancer trial of TPA plus Dexamethasone and CMT in leukemia was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CMT
• DEXAMETHASONE (Dexamethasone)
• tPA (tissue plasminogen activator)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2015-06-22